R. Huang

发表

Mapping genes that contribute to daunorubicin-induced cytotoxicity.

S. Duan, W. K. Bleibel, J. Badner, 2007, Cancer research.

Consistency in large pharmacogenomic studies

Nancy J. Cox, Eric R. Gamazon, Cathal Seoighe, 2016, Nature.

Pharmacogenomics discovery and implementation in genome‐wide association studies era

Wei Zhang, R. Huang, Xiuqin Ni, 2013, Wiley interdisciplinary reviews. Systems biology and medicine.

A genome-wide integrative study of microRNAs in human liver

E. Gamazon, M. Ratain, F. Innocenti, 2013, BMC Genomics.

Effect of population and gender on chemotherapeutic agent–induced cytotoxicity

Sunita J Shukla, M Eileen Dolan, E. Kistner, 2006, Molecular Cancer Therapeutics.

Discovering drugs to overcome chemoresistance in ovarian cancers based on the cancer genome atlas tumor transcriptome profile

Fan Wang, Zhenyu Zhang, A. Nath, 2017, Oncotarget.

Poly‐Omic Prediction of Complex Traits: OmicKriging

Hae Kyung Im, R Stephanie Huang, Nancy J Cox, 2013, Genetic epidemiology.

The impact of microRNA expression on cellular proliferation

E. Gamazon, H. Im, B. LaCroix, 2014, Human Genetics.

The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment

R. Stephanie Huang, Shoshana Rudin, Marcus Marable, 2017, Genom. Proteom. Bioinform..

Long non-coding RNA transcriptome of uncharacterized samples can be accurately imputed using protein-coding genes

R Stephanie Huang, Aritro Nath, Paul Geeleher, 2019, Briefings Bioinform..

Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer

R. Stephanie Huang, Maimon C. Rose, Elina Kostyanovskaya, 2014, Genom. Proteom. Bioinform..

Integrative analyses of genetic variation, epigenetic regulation, and the transcriptome to elucidate the biology of platinum sensitivity

Hae Kyung Im, Paul Geeleher, Nancy J Cox, 2014, BMC Genomics.

Genetic Variation That Predicts Platinum Sensitivity Reveals the Role of miR-193b* in Chemotherapeutic Susceptibility

E. Gamazon, D. Ziliak, B. LaCroix, 2012, Molecular Cancer Therapeutics.

Preclinical Development Genetic Variation That Predicts Platinum Sensitivity Reveals the Role of miR-193 b in Chemotherapeutic Susceptibility

E. Gamazon, H. Im, D. Ziliak, 2012 .

Identification of novel germline polymorphisms governing capecitabine sensitivity

E. Gamazon, H. Im, M. Dolan, 2012, Cancer.

Comprehensive Evaluation of the Contribution of X Chromosome Genes to Platinum Sensitivity

E. Gamazon, H. Im, M. Dolan, 2011, Molecular Cancer Therapeutics.

PACdb: a database for cell-based pharmacogenomics.

Wei Zhang, Shiwei Duan, Nancy J Cox, 2010, Pharmacogenetics and genomics.

Identification of genetic variants and gene expression relationships associated with pharmacogenes in humans

Wei Zhang, Shiwei Duan, Nancy J Cox, 2008, Pharmacogenetics and genomics.

Cancer biomarker discovery is improved by accounting for variability in general levels of drug sensitivity in pre-clinical models

N. Cox, R. S. Huang, Paul Geeleher, 2016, Genome Biology.

The impact of microRNA expression on cellular proliferation

E. Gamazon, H. Im, B. LaCroix, 2014, Human Genetics.

Abstract 5561: Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines

R. S. Huang, R. Huang, N. Cox, 2014 .

Discovering novel long non-coding RNA predictors of anticancer drug sensitivity beyond protein-coding genes

R. S. Huang, Paul Geeleher, Adam M. Lee, 2019, bioRxiv.

Genetic architecture of microRNA expression: implications for the transcriptome and complex traits.

Danny S. Park, N. Cox, E. Gamazon, 2012, American journal of human genetics.

Pharmacogenomic Discovery Using Cell-Based Models

Marisa Wong Medina, M. Eileen Dolan, Lara Mangravite, 2009, Pharmacological Reviews.

Integrative “Omic” Analysis for Tamoxifen Sensitivity through Cell Based Models

R. S. Huang, L. Weng, D. Ziliak, 2014, PloS one.

Evaluation of genetic variation contributing to differences in gene expression between populations.

Tyson A. Clark, A. Schweitzer, J. Blume, 2008, American journal of human genetics.

Identification of common genetic variants that account for transcript isoform variation between human populations

Lijun He, M. Eileen Dolan, Wei Zhang, 2008, Human Genetics.

An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.

K. White, M. Dolan, R. S. Huang, 2011, Seminars in oncology.

Population differences in microRNA expression and biological implications

E. Gamazon, H. Im, S. Duan, 2011, RNA biology.

SCAN: a systems biology approach to pharmacogenomic discovery.

Nancy J Cox, Eric R Gamazon, E. Gamazon, 2013, Methods in molecular biology.

Pharmacogenomics of EGFR-targeted therapies in non–small cell lung cancer: EGFR and beyond

R. S. Huang, R. Huang, C. Delaney, 2015, Chinese journal of cancer.

An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.

Megan E. McNerney, K. White, M. Dolan, 2011, Seminars in Oncology.

Population-specific GSTM1 copy number variation.

E. Cook, S. Duan, M. Dolan, 2009, Human molecular genetics.

Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines

N. Cox, R. S. Huang, Paul Geeleher, 2014, Genome Biology.

Evaluation of genetic variation contributing to differences in gene expression between populations.

Tyson A. Clark, A. Schweitzer, J. Blume, 2008, American journal of human genetics.